ACE Report Cover
Addition of epinephrine to popliteal nerve block does not extend analgesia in ankle fusion
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descargar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Idioma
Download Download Download
Descargar
Cite this Report Cite this Report Cite this Report
Citar
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoritos
FOOT & ANKLE
Addition of epinephrine to popliteal nerve block does not extend analgesia in ankle fusion .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2015;3(19):7 BMC Anesthesiol. 2015 Jul 10;15:100

38 patients patients scheduled for ankle fusion and/or subtalar fusion under continuous popliteal sciatic nerve block were randomized to receive 30 mL ropivacaine (0.75%) with or without the addition of epinephrine (5 ug/mL). The purpose of the study was to determine how the duration of postoperative analgesia was affected by the addition of epinephrine, as measured by the time elapsed from poplitear catheter placement until the time of first request for postoperative analgesia via patient controlled analgesia. Results indicated that the duration of postoperative analgesia was not significantly increased with the addition of epinephrine to ropivacaine for continuous popliteal nerve block.


Detalles de la financiación de la publicación +
Financiación:
Non-Industry funded
Patrocinador:
Internal funds from the department of Anaesthesiology, Sint Maartenskliniek, Nijmegen, The Netherlands.
Conflictos:
None disclosed

Riesgo de sesgo

8/10

Criterios de información

19/20

Índice de fragilidad

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sí = 1

Incierto = 0,5

No relevante = 0

No = 0

La evaluación de los criterios de información evalúa la transparencia con la que los autores informan de las características metodológicas y del ensayo dentro de la publicación. La evaluación se divide en cinco categorías que se presentan a continuación.

3/4

Randomization

4/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

El Índice de Fragilidad es una herramienta que ayuda en la interpretación de hallazgos significativos, proporcionando una medida de fuerza para un resultado. El Índice de Fragilidad representa el número de eventos consecutivos que es necesario añadir a un resultado dicotómico para que el hallazgo deje de ser significativo. Un número pequeño representa un hallazgo más débil y un número grande un hallazgo más fuerte.

¿Por qué se necesitaba ahora este estudio?

Peripheral nerve block is often used for analgesia in ankle surgery. While the choice of local anaesthetic agent used in popliteal nerve blocks impacts efficacy, it has been suggested that so too does the addition of epinephrine. The theory behind the addition of epinephrine to local anaesthetic is to reduce local plasma concentration via vasoconstriction and slow absorption, thereby increasing the duration of analgesia. The current literature was limited in relation to this treatment, and thus the present study was conducted.

¿Cuál era la pregunta principal de la investigación?

In ankle and subtalar fusion under popliteal nerve block, how does time to first request for postoperative anaglesia compare between blocks performed with 30 mL ropivacaine (0.75%), with and without the addition of epinephrine?

Características del estudio +
Población:
38 patients (18 years of age or older) scheduled for ankle fusion and/or subtalar fusion under continuous popliteal sciatic nerve block. All patients received paracetamol 1000mg orally 3x/day and etoricoxib 90mg orally once/day, starting on the morning of surgery for at least 7 days. Patient controlled analgesia (PCA) (GemStar, Hospira Inc) was used for postoperative analgesia, with bolus doses of 10mL ropivacaine 0.2% and 15 minute lock out time, and max dose of 30mL/4hours. If patients still needed pain medication, they received morphine 0.1-0.15 mg/kg every 4 hours subcutaneously (30 completed follow-up).
Intervención:
ROPI-EPI group: received ultrasound guided continuous popliteal nerve block with 30 mL ropivacaine (0.75%) with epinephrine (5 ug/mL) (n=18, 15 completed follow-up, Mean age: 56 +/- 11, 9M/6F).
Comparación:
ROPI group: received ultrasound guided continuous popliteal nerve block with 30 mL ropivacaine (0.75%) without epinephrine (n=20, 15 completed follow-up, Mean age: 61 +/- 7, 8M/7F).
Resultados:
The primary outcome measure was the duration of postoperative analgesia defined as the time to first request for postoperative analgesia (TTFR) via PCA, where TTFR was defined as the time elapsed from t=0 (placement of popliteal catheter) until the time of first request. Secondary outcomes included the onset of sensory and motor block, and Numeric Rating Scale (NRS) score for pain at rest and during movement. Sensory block, as well as motor function of the tibial (plantar flexion foot) and peroneal nerve (dorsal flexion of the foot), were scored on a three point scale (0=absent, 1=partial, 2=complete).
Métodos:
RCT, prospective, double-blinded, single-centered.
Tiempo:
Outcomes were assessed immediately, at 24h, and at 48h postoperatively.
¿Cuáles fueron los hallazgos importantes?
  • Median [interquartile range] TTFR for postoperative analgesia was 463 [300-1197] min in the ROPI group and 830 [397-1128] min in the ROPI-EPI group; the difference between groups in TTFR was not statistically significant (p=0.56).
  • There was no significant difference noted between groups in terms of NRS rest at 24 h (p=0.70), NRS movement at 24 h (p=0.47), NRS max during 24 h (p=0.17), or NRS satisfaction with the block (p=0.08).
  • In the ROPI group, 4 patients received complete block in tibial sensory, 10 in tibial motor, 12 in peroneal sensory, and 11 in peroneal motor. In the ROPI-EPI group, 9 patients received complete block in tibial sensory, 9 in tibial motor, 11 in peroneal sensory, and 10 in peroneal motor.
  • No patients displayed signs of local anesthetic toxicity or inadvertent intravascular injection of epinephrine.
¿Qué es lo que más debo recordar?

Duration of postoperative analgesia, as measured by the time to first request for postoperative analgesia, was not significantly increased via the addition of epinephrine to ropivacaine for popliteal nerve block in ankle and/or subtalar fusion. Additionally, no significant differences were noted in any clinical outcome between the group receiving epinephrine and the group that did not.

¿Cómo afectará esto al cuidado de mis pacientes?

The results of this study indicate that the addition of epinephrine to ropivacaine treatment in popliteal nerve block may not significantly increase the duration of postoperative analgesia. Further high quality evidence, including larger sample sizes, is required before firm decisions regarding the use of epinephrine in this treatment are made in the clinical field.

DESCARGO DE RESPONSABILIDAD

El contenido de esta página tiene únicamente fines informativos y no pretende sustituir el consejo, diagnóstico o tratamiento médico profesional. Si necesita tratamiento médico, busque siempre el consejo de su médico o acuda al servicio de urgencias más cercano. Las opiniones, creencias y puntos de vista expresados por las personas sobre el contenido que se encuentra en esta página no reflejan las opiniones, creencias y puntos de vista de OrthoEvidence.

0 de 4 artículos mensuales GRATIS desbloqueados
Ha alcanzado su límite de vistas de 4 artículos gratuitos este mes

Acceda a OrtoEvidencia por tan sólo 1,99 $ a la semana.

Manténgase conectado con las últimas pruebas. Cancele en cualquier momento.
  • Valoraciones críticas de los últimos ensayos controlados aleatorizados de gran impacto y revisiones sistemáticas en ortopedia
  • Acceso al contenido del podcast OrthoEvidence, que incluye colaboraciones con el Journal of Bone and Joint Surgery, entrevistas con cirujanos reconocidos internacionalmente y mesas redondas sobre noticias y temas ortopédicos
  • Suscripción a The Pulse, un boletín quincenal basado en la evidencia y diseñado para ayudarle a tomar mejores decisiones clínicas
Upgrade
Close Dialog
Bienvenido
¿Ha olvidado su contraseña?
Comience hoy mismo su prueba GRATUITA

Su cuenta estará afiliada a
e incluye acceso gratuito a OrthoEvidence


O
¿Olvidó su contraseña?

O
Compruebe su correo electrónico

Si existe una cuenta con la dirección de correo electrónico proporcionada, se le enviará un correo electrónico para restablecer la contraseña. Si no ve el correo electrónico, compruebe su carpeta de correo no deseado o spam.

Si necesita más ayuda póngase en contacto con nuestro equipo de asistencia.

Inicie sesión para activar esta función

Para acceder a esta función, debe iniciar sesión en una cuenta activa de OrthoEvidence. Por favor, inicie sesión o cree una cuenta de prueba GRATUITA.

Traducir Informe ACE

OrthoEvidence utiliza un servicio de traducción de terceros para que el contenido sea accesible en varios idiomas. Tenga en cuenta que, aunque se hace todo lo posible para garantizar la exactitud, las traducciones no siempre son perfectas.

Cómo citar esto ACE Report

OrthoEvidence. Addition of epinephrine to popliteal nerve block does not extend analgesia in ankle fusion. OE Journal. 2015;3(19):7. Available from: https://myorthoevidence.com/AceReport/Show/addition-of-epinephrine-to-popliteal-nerve-block-does-not-extend-analgesia-in-ankle-fusion

Copiar cita
Inicie sesión para activar esta función

Para acceder a esta función, debe iniciar sesión en una cuenta activa de OrthoEvidence. Por favor, inicie sesión o cree una cuenta de prueba GRATUITA.

Función de miembro Premium

Para acceder a esta función, debe iniciar sesión en una cuenta Premium de OrthoEvidence.

Compartir ACE Report